Ningxia Zhongke Biotechnology Co., Ltd (SHA:600165)

China · Delayed Price · Currency is CNY

2.330

+0.030 (1.30%)

Jul 31, 2026, 3:00 PM CST

SHA:600165 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	468.31	444.48	345.32	285.69	681.13	248.72
Revenue Growth	21.56%	28.72%	20.87%	-58.06%	173.86%	108.80%
Gross Profit	-165.66	-201.73	-133.57	-133.82	46.45	-138.43
Operating Income	-285.83	-321.97	-208.31	-202.18	-87.41	-200.22
Net Income	-90.62	-90.38	-538.91	-464.71	-141.48	-166.09
Earnings Per Share	-0.05	-0.06	-0.79	-0.68	-0.21	-0.24
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Activated Carbon Business	184.48
Lauric Acid	260.08
Offset of Business Segment	-0.08
Total	444.48

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	272.49	460.65	8.61	24.4	89.48	110.95
Total Debt	861.27	857.36	677.27	1,704	1,615	1,500
Net Cash (Debt)	-588.78	-396.71	-668.67	-1,679	-1,526	-1,389
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.32	-0.25	-0.98	-2.45	-2.23	-2.03

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-452.4	-373.4	-85.19	23.15	53.14	-17.93
Capital Expenditures	-291.27	-271.17	-6.2	-57.68	-59.31	-240.39
Free Cash Flow	-743.67	-644.57	-91.39	-34.53	-6.17	-258.32
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	-35.37%	-45.38%	-38.68%	-46.84%	6.82%	-55.66%
Operating Margin	-61.03%	-72.44%	-60.32%	-70.77%	-12.83%	-80.50%
Pretax Margin	-31.66%	-35.54%	-167.69%	-180.46%	-24.33%	-75.21%
Profit Margin	-19.35%	-20.33%	-156.06%	-162.66%	-20.77%	-66.78%
FCF Margin	-158.80%	-145.02%	-26.47%	-12.09%	-0.91%	-103.86%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	33.67	33.67	33.67	37.56	-
PS Ratio	8.04	15.09	4.82	8.10	6.80	36.98